ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Clinical trials for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tracking Kids' health years after brain tumor treatment
Disease control OngoingThis study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effe…
Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Targeted drug duo aims to control aggressive pediatric brain cancer
Disease control OngoingThis study is testing whether adding two targeted drugs, dabrafenib and trametinib, after standard radiation therapy works better for children and young adults with a specific type of aggressive brain tumor. The treatment is for patients whose tumors have a particular genetic cha…
Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC